Yersinia pestis acrAB-tolC in antibiotic resistance and virulence

Antimicrobial Agents and Chemotherapy

Volumn 56, Issue 2, 2012, Pages 1120-1123

  Lister, Ida M ^a   Raftery, Connor ^a   Mecsas, Joan ^a   Levy, Stuart B ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE; ARGININE; CHLORAMPHENICOL; MACROLIDE; NALIDIXIC ACID; PHENYLALANINE; POLYMYXIN B; TETRACYCLINE; TOLC PROTEIN;

ANIMAL EXPERIMENT; ANTIBIOTIC RESISTANCE; ARTICLE; CONTROLLED STUDY; ERWINIA AMYLOVORA; ESCHERICHIA COLI; FRANCISELLA TULARENSIS; KLEBSIELLA PNEUMONIAE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; SALMONELLA ENTERICA; VIBRIO CHOLERAE; VIRULENCE; YERSINIA PESTIS;

ANIMALS; ANTI-BACTERIAL AGENTS; BACTERIAL OUTER MEMBRANE PROTEINS; BACTERIAL PROTEINS; DRUG RESISTANCE, BACTERIAL; FEMALE; GENE DELETION; HUMANS; MEMBRANE TRANSPORT PROTEINS; MICE; MICE, INBRED BALB C; MICROBIAL SENSITIVITY TESTS; PLAGUE; VIRULENCE; YERSINIA PESTIS;

EID: 84856070744     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.05338-11     Document Type: Article

References (42)

1. Barbosa TM, Levy SB. 2000. Differential expression of over 60 chromosomal genes in Escherichia coli by constitutive expression of MarA. J. Bacteriol. 182:3467-3474. (Pubitemid 30341610)
2. Bhor VM, Thomas CJ, Surolia N, Surolia A. 2005. Polymyxin B: an ode to an old antidote for endotoxic shock. Mol. Biosyst. 1:213-222. (Pubitemid 41442431)
3. Bina XR, Lavine CL, Miller MA, Bina JE. 2008. The AcrAB RND efflux system from the live vaccine strain of Francisella tularensis is a multiple drug efflux system that is required for virulence in mice. FEMS Microbiol. Lett. 279:226-233.
4. Bohnert JA, Kern WV. 2005. Selected arylpiperazines are capable of reversing multidrug resistance in Escherichia coli overexpressing RND efflux pumps. Antimicrob. Agents Chemother. 49:849-852. (Pubitemid 40175716)
5. Bulet P, Stocklin R, Menin L. 2004. Anti-microbial peptides: from invertebrates to vertebrates. Immunol. Rev. 198:169-184. (Pubitemid 38406943)
6. Chatterjee A, Chaudhuri S, Saha G, Gupta S, Chowdhury R. 2004. Effect of bile on the cell surface permeability barrier and efflux system of Vibrio cholerae. J. Bacteriol. 186:6809-6814. (Pubitemid 39332119)
7. Elkins CA, Mullis LB. 2006. Mammalian steroid hormones are substrates for the major RND- and MFS-type tripartite multidrug efflux pumps of Escherichia coli. J. Bacteriol. 188:1191-1195. (Pubitemid 43146439)
8. Escribano I, Rodriguez JC, Pertegas V, Cebrian L, Royo G. 2006. Relation between induction of the mar operon and cyclohexane tolerance and reduction in fluoroquinolone susceptibility in Salmonella spp. J. Infect. Chemother. 12:177-180. (Pubitemid 44327184)
9. Galimand M, Carniel E, Courvalin P. 2006. Resistance of Yersinia pestis to antimicrobial agents. Antimicrob. Agents Chemother. 50:3233-3236. (Pubitemid 44527492)
10. Hasdemir UO, Chevalier J, Nordmann P, Pages JM. 2004. Detection and prevalence of active drug efflux mechanism in various multidrug-resistant Klebsiella pneumoniae strains from Turkey. J. Clin. Microbiol. 42:2701-2706. (Pubitemid 38747524)
11. Heckman KL, Pease LR. 2007. Gene splicing and mutagenesis by PCR-driven overlap extension. Nat. Protoc. 2:924-932. (Pubitemid 46758810)
12. Izadpanah, A., and R. L. Gallo. 2005. Antimicrobial peptides. J. Am. Acad. Dermatol. 52:381-390; quiz, 391-392.
13. Jenssen H, Hamill P, Hancock RE. 2006. Peptide antimicrobial agents. Clin. Microbiol. Rev. 19:491-511. (Pubitemid 44137212)
14. Jerse AE, et al. 2003. A gonococcal efflux pump system enhances bacterial survival in a female mouse model of genital tract infection. Infect. Immun. 71:5576-5582. (Pubitemid 37205608)
15. Kaczmarek FS, et al. 2004. Genetic and molecular characterization of {beta}-lactamase-negative ampicillin-resistant Haemophilus influenzae with unusually high resistance to ampicillin. Antimicrob. Agents Chemother. 48:1630-1639. (Pubitemid 38544368)
16. Kern WV, et al. 2006. Effect of 1-(1-naphthylmethyl)-piperazine, a novel putative efflux pump inhibitor, on antimicrobial drug susceptibility in clinical isolates of Escherichia coli. J. Antimicrob. Chemother. 57:339-343. (Pubitemid 43160180)
17. Kwa AL, Tam VH, Falagas ME. 2008. Polymyxins: a review of the current status including recent developments. Ann. Acad. Med. Singapore 37:870-883.
18. Lahteenmaki K, Virkola R, Saren A, Emody L, Korhonen TK. 1998. Expression of plasminogen activator pla of Yersinia pestis enhances bacterial attachment to the mammalian extracellular matrix. Infect. Immun. 66:5755-5762. (Pubitemid 28531831)
19. Lister IM, Mecsas J, Levy SB. 2010. Effect of MarA-like proteins on antibiotic resistance and virulence in Yersinia pestis. Infect. Immun. 78:364-371.
20. Lomovskaya O, Bostian KA. 2006. Practical applications and feasibility of efflux pump inhibitors in the clinic - a vision for applied use. Biochem. Pharmacol. 71:910-918.
21. Lomovskaya O, et al. 2001. Identification and characterization of inhibitors of multidrug resistance efflux pumps in Pseudomonas aeruginosa: novel agents for combination therapy. Antimicrob. Agents Chemother. 45:105-116. (Pubitemid 32039101)
22. Mazzariol A, Zuliani J, Cornaglia G, Rossolini GM, Fontana R. 2002. AcrAB efflux system: expression and contribution to fluoroquinolone resistance in Klebsiella spp. Antimicrob. Agents Chemother. 46:3984-3986. (Pubitemid 35403279)
23. Nikaido E, Yamaguchi A, Nishino K. 2008. AcrAB multidrug efflux pump regulation in Salmonella enterica serovar Typhimurium by RamA in response to environmental signals. J. Biol. Chem. 283:24245-24253.
24. Nikaido H. 2009. Multidrug resistance in bacteria. Annu. Rev. Biochem. 78:119-146.
25. Nikaido H, Takatsuka Y. 2009. Mechanisms of RND multidrug efflux pumps. Biochim. Biophys. Acta 1794:769-781.
26. Nishino K, Yamaguchi A. 2001. Analysis of a complete library of putative drug transporter genes in Escherichia coli. J. Bacteriol. 183:5803-5812. (Pubitemid 32917397)
27. Padilla E, et al. 2010. Klebsiella pneumoniae AcrAB efflux pump contributes to antimicrobial resistance and virulence. Antimicrob. Agents Chemother. 54:177-183.
28. Parent MA, et al. 2005. Cell-mediated protection against pulmonary Yersinia pestis infection. Infect. Immun. 73:7304-7310. (Pubitemid 41587630)
29. Pasquali F, Manfreda G. 2007. Mutant prevention concentration of ciprofloxacin and enrofloxacin against Escherichia coli, Salmonella Typhimurium and Pseudomonas aeruginosa. Vet. Microbiol. 119:304-310. (Pubitemid 46027447)
30. Piddock LJ. 2006. Multidrug-resistance efflux pumps - not just for resistance. Nat. Rev. Microbiol. 4:629-636. (Pubitemid 44317025)
31. Pomposiello PJ, Bennik MH, Demple B. 2001. Genome-wide transcriptional profiling of the Escherichia coli responses to superoxide stress and sodium salicylate. J. Bacteriol. 183:3890-3902. (Pubitemid 32565468)
32. Rosner JL, Martin RG. 2009. An excretory function for the Escherichia coli outer membrane pore TolC: upregulation of marA and soxS transcription and rob activity due to metabolites accumulated in tolC mutants. J. Bacteriol. 191:5283-5292.
33. Saenz Y, et al. 2004. Effect of the efflux pump inhibitor Phe-Arg-beta-naphthylamide on the MIC values of the quinolones, tetracycline and chloramphenicol, in Escherichia coli isolates of different origin. J. Antimicrob. Chemother. 53:544-545. (Pubitemid 38380260)
34. Shafer WM, Qu X, Waring AJ, Lehrer RI. 1998. Modulation of Neisseria gonorrhoeae susceptibility to vertebrate antibacterial peptides due to a member of the resistance/nodulation/division efflux pump family. Proc. Natl. Acad. Sci. U. S. A. 95:1829-1833. (Pubitemid 28103479)
35. Sulavik MC, et al. 2001. Antibiotic susceptibility profiles of Escherichia coli strains lacking multidrug efflux pump genes. Antimicrob. Agents Chemother. 45:1126-1136. (Pubitemid 32230993)
36. Thanassi DG, Cheng LW, Nikaido H. 1997. Active efflux of bile salts by Escherichia coli. J. Bacteriol. 179:2512-2518. (Pubitemid 27164547)
37. Tzeng YL, et al. 2005. Cationic antimicrobial peptide resistance in Neisseria meningitidis. J. Bacteriol. 187:5387-5396.
38. Une T, Brubaker RR. 1984. In vivo comparison of avirulent Vwa- and Pgm- or Pstr phenotypes of yersiniae. Infect. Immun. 43:895-900. (Pubitemid 14192806)
39. Wang H, Dzink-Fox JL, Chen M, Levy SB. 2001. Genetic characterization of highly fluoroquinolone-resistant clinical Escherichia coli strains from China: role of acrR mutations. Antimicrob. Agents Chemother. 45:1515-1521. (Pubitemid 32374127)
40. Warner DM, Levy SB. 2010. Different effects of transcriptional regulators marA, soxS, and rob on susceptibility of Escherichia coli to cationic antimicrobial peptides (CAMPs): Rob-dependent CAMP induction of the marRAB operon. Microbiology 156:570-578.
41. Yang H, et al. 2008. The AcrAB-TolC pump is involved in multidrug resistance in clinical Shigella flexneri isolates. Microb. Drug Resist. 14:245-249.
42. Yu EW, Aires JR, McDermott G, Nikaido H. 2005. A periplasmic drug-binding site of the AcrB multidrug efflux pump: a crystallographic and site-directed mutagenesis study. J. Bacteriol. 187:6804-6815. (Pubitemid 41356254)